Corporation

VeriSci specializes in electrophysiological devices for assessment of visual function. The Neucodia system (FDA cleared) integrates cutting-edge technologies, superior engineering, and protocols for the latest scientific discoveries in the field. Currently, VeriSci is involved in clinical testing in collaboration with leading universities and hospitals across the U.S. to advance novel electrophysiological applications in the clinic. Our newest model of the device can be configured for a variety of applications that involve visual disorders including early-stage glaucoma, amblyopia, diabetic retinopathy and other neurological disorders. Check our Product section for more information.